Cargando…

Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)

Detalles Bibliográficos
Autores principales:	Pérez, L, Aleman, J, Correa, C, Pérez, J, Fonseca, C, Aragones, C, Pérez, D, Alvarez, A, Vandamme, AM, Kourí, V, Van Laethem, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112918/ http://dx.doi.org/10.1186/1758-2652-13-S4-P141

Ejemplares similares

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba
por: Alemán, Yoan, et al.
Publicado: (2015)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba
por: Kouri, Vivian, et al.
Publicado: (2015)

A7 Co-receptor tropism determined by genotypic assay in HIV-1 non-B subtypes circulating in Cuba: Implications for pathogenesis and Maraviroc resistance
por: Méndez, M, et al.
Publicado: (2019)

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
por: Vilaplana, Vicente Escudero, et al.
Publicado: (2010)

Emergence of HIV-1 drug resistance in antiretroviral therapy experienced perinatally infected children in South India
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
por: Maroldo, L, et al.
Publicado: (2010)

Deciphering leptospirosis eco-epidemiology in New Caledonia
por: Perez, J, et al.
Publicado: (2011)

HIV-related morbidity rate, thirteen years after the introduction of highly active antiretroviral therapy (1996-2009)
por: Manfredi, Roberto
Publicado: (2010)

Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple-experienced HIV1- and HIV2-infected patients
por: Doroana, M, et al.
Publicado: (2010)

Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba
por: Hopman, J, et al.
Publicado: (2011)

Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
por: Palacios, R, et al.
Publicado: (2010)

Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen
por: Wikman, P, et al.
Publicado: (2010)

Rapid Diagnosis of Pandemic (H1N1) 2009 in Cuba
por: Acosta, Belsy, et al.
Publicado: (2012)

Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia
por: Bloch, M, et al.
Publicado: (2010)

Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.
por: Kourí, G, et al.
Publicado: (1998)

Antiretroviral regimen complexity as a predictor of adherence
por: Boyle, C, et al.
Publicado: (2010)

Cuba : between reform and revolution /
por: Pérez, Louis A., 1943-
Publicado: (1995)

Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010)

Use of antiretroviral therapy during pregnancy among HIV-infected women attending an urban care centre
por: Ssewankambo, F, et al.
Publicado: (2010)

Difficulties in controlling HIV and TB infections in multi-experienced patients
por: Benea, Șerban, et al.
Publicado: (2014)

Molecular epidemiology and drug resistance prevalence of strains from newly diagnosed HIV-1 patients in Northern Greece during 2009-2010
por: Antoniadou, Zoe, et al.
Publicado: (2012)

Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients
por: Caldas, C, et al.
Publicado: (2010)

Clinical epidemiology and molecular analysis of hospitalized children with hand-foot and mouth disease during 2009 in Shanghai
por: Yu, H, et al.
Publicado: (2011)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
por: Bayingana, R, et al.
Publicado: (2012)

Dengue Virus Type 3, Cuba, 2000–2002
por: Rodriguez-Roche, Rosmari, et al.
Publicado: (2005)

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
por: Ghosn, J, et al.
Publicado: (2010)

Characterization of potential donors of multiple organs and tissues reported in Maranhão from 2009 to 2012
por: Correa, TM, et al.
Publicado: (2013)

HIV patients admitted to an ICU of a university hospital - experience of 15 years: 1995 to 2009
por: Agrifoglio, A, et al.
Publicado: (2013)

Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010)

Clinical outcome in patients who experienced inhospital cardiac arrest by underlying disease
por: Shin, Y, et al.
Publicado: (2009)

Historiografía de Cuba
por: Pérez Cabrera, José Manuel, 1901-
Publicado: (1962)

P240: Necrotising enterocolitis in preterm infants: epidemiology and antibiotic consumption in the Polish neonatology surveillance network neonatal intensive care units in 2009
por: Wojkowska-Mach, J, et al.
Publicado: (2013)

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates
por: Golf, JP, et al.
Publicado: (2010)

Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment
por: Perez-Molina, JA, et al.
Publicado: (2010)

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis
por: Brinson, Cynthia, et al.
Publicado: (2014)

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
por: Schneider, L, et al.
Publicado: (2010)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients
por: Jansen, K, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7bd1ujcoqm30oeva7amvfeptrh